Amine

Europe PMC · from cache · sorted by publication date

1. 1
   Design, synthesis, and antibacterial activity study of pyrroloquinazoline diamine derivatives.

   Cheng M, Tian Y, Shang J, He W, Zheng Y, Yan C, Chen X, Li J, Jiang Y, Fu Q, Deng X, Xiao X, Song M. · 2026-06-24

   open access unreviewed
2. 2
   Impact of oliceridine versus sufentanil on postoperative nausea and vomiting in patients undergoing thyroid surgery: a prospective, double-blind, randomized controlled trial.

   Liu F, Shen W, Su D, Guan Z, Zhang Y, Li S, Yuan Q, Zhao Y, Sun J, Fang H, Yang L. · 2026-06-24

   open access unreviewed
3. 3
   Metabolic profile association with white matter hyperintensity in patients with mild cognitive impairment.

   Ariaei A, Zamiri R, Ghasemi A, Rezayani B, Rezayani S, Ezatpour A, Farshidi N, Sheikhi EA, Roghanian A, Alzhe… · 2026-06-09

   open access unreviewed
4. 4
   Research progress of ferroptosis in gynecological diseases.

   Chen W, Zhou W, Liu S. · 2026-06-19

   open access unreviewed
5. 5
   Design, synthesis, and biological evaluation of 6-aryl-3-(3,4,5-trimethoxyphenyl)imidazo[1,2-a]pyridine derivatives as novel tubulin inhibitors with potent anticancer efficacy.

   Xu W, Zhang Y, Xu Q, Zhao H, Cui L, Wang C. · 2026-06-17

   open access unreviewed
6. 6
   Mechanical reinforcement of gellan-alginate hydrogels using commercial functionalized silica particles and mild surface chemistry.

   Segovia-Gutiérrez JP, Agudo JAR, Wengler-Rust S, Binder N, Weidler PG, Kirschhöfer F, Utz J, Germann N. · 2026-06-09

   unreviewed
7. 7
   Recent advances and clinical relevance of microbiome dynamics in health and disease.

   Gavanji S, Suhail M, Bencurova E, Dandekar T, Othman EM. · 2026-06-12

   open access unreviewed
8. 8
   Systems engineering of <i>Escherichia coli</i> for high-level hydroxytyrosol production.

   Zuo J, Zhang S, Huang W, Liu J, Gao C, Hu GP, Song W, Li X, Wei W, Wu J, Liu L, Liu K, Xu N. · 2026-06-01

   open access unreviewed
9. 9
   Enzymatic and non-enzymatic oxidation of fibrillar collagen.

   Mathias-Netto FC, Cantuária NM, Gaspar RS. · 2026-06-11

   cited 1× open access unreviewed
10. 10
    Discovery and optimization of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor for the treatment of hemophilia A and B.

    Jin M, Hett S, Jasuja R, Rakhe S, Narula J, Tam A, Apgar JR, Juo ZS, Mosyak L, Holsti M, Joyce A, Hurst S, We… · 2026-06-11

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.